Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Developmental Biology|January 4, 2006
Intrinsic and extrinsic inhibition of oligodendrocyte development by rat retinaLimin Gao, Wendy Macklin, James Gerson, et al.
Cold Spring Harbor Molecular Case Studies|January 10, 2024
PD-L1+ diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquired PMS2 mutationAndrew W Allbee, James Gerson, Guang Yang, et al.
Cardio-Oncology (London, England)|June 2, 2024
Cardiotoxicity from bruton tyrosine kinase inhibitors (BTKi)-an analysis of an administrative health claims databaseSrilakshmi Vallabhaneni, Srinath Adusumalli, Jingyi Wu, et al.
Haematologica|May 17, 2020
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomasJakub Svoboda, Steven M Bair, Daniel J Landsburg, et al.
Blood Advances|July 24, 2025
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysisNausheen Ahmed, Swetha Thiruvengadam, Mehdi Hamadani, et al.
Cancer Discovery|July 29, 2022
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against CancerYong Gu Lee, Puneeth Guruprasad, Guido Ghilardi, et al.
The New England Journal of Medicine|May 7, 2025
Enhanced CAR T-Cell Therapy for Lymphoma after Previous FailureJakub Svoboda, Daniel J Landsburg, James Gerson, et al.
Nature Medicine|March 15, 2022
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Anqi Dai, Guido Ghilardi, et al.
Pageof 1